KR101064934B1 - Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi - Google Patents

Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi Download PDF

Info

Publication number
KR101064934B1
KR101064934B1 KR1020100009333A KR20100009333A KR101064934B1 KR 101064934 B1 KR101064934 B1 KR 101064934B1 KR 1020100009333 A KR1020100009333 A KR 1020100009333A KR 20100009333 A KR20100009333 A KR 20100009333A KR 101064934 B1 KR101064934 B1 KR 101064934B1
Authority
KR
South Korea
Prior art keywords
vitamin
skin
kiwi
cosmetic composition
actinidine
Prior art date
Application number
KR1020100009333A
Other languages
Korean (ko)
Other versions
KR20110089786A (en
Inventor
우윤택
안기웅
조병기
Original Assignee
(주)더페이스샵
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)더페이스샵 filed Critical (주)더페이스샵
Priority to KR1020100009333A priority Critical patent/KR101064934B1/en
Publication of KR20110089786A publication Critical patent/KR20110089786A/en
Application granted granted Critical
Publication of KR101064934B1 publication Critical patent/KR101064934B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

본 발명은 비타민 C와 키위에서 유래된 악티니딘(Actinidin)을 함유하는 미백 화장료 조성물에 관한 것으로, 미백효과가 우수한 비타민 C와 키위에서 유래된 악티니딘이 피부 바깥쪽에 있는 각질층의 제거를 촉진하여 자극없이 피부의 미백효과를 증진하는 화장료 조성물에 관한 것이다.The present invention relates to a whitening cosmetic composition containing actinidine (Actinidin) derived from vitamin C and kiwi, and the actinidedine derived from vitamin C and kiwi having excellent whitening effect promotes the removal of the stratum corneum outside the skin. It relates to a cosmetic composition to enhance the skin whitening effect without irritation.

Description

비타민 C 와 키위에서 유래된 악티니딘을 함유하는 피부 미백용 화장료 조성물 {Cosmetic Composition comprising Vitamin C and Actinidin derived from Kiwifruit for Skin Whitening}Cosmetic composition comprising Vitamin C and Actinidin derived from Kiwifruit for Skin Whitening}

본 발명은 비타민 C와 키위에서 유래된 악티니딘(Actinidin)을 함유하는 미백 화장료 조성물에 관한 것으로, 미백효과가 우수한 비타민 C와 키위에서 유래된 악티니딘이 피부 바깥쪽에 있는 각질층의 제거를 촉진하여 자극없이 피부의 미백효과를 증진하는 화장료 조성물에 관한 것이다.The present invention relates to a whitening cosmetic composition containing actinidine (Actinidin) derived from vitamin C and kiwi, and the actinidedine derived from vitamin C and kiwi having excellent whitening effect promotes the removal of the stratum corneum outside the skin. It relates to a cosmetic composition to enhance the skin whitening effect without irritation.

사람의 피부색은 크게 멜라닌의 양, 헤모글로빈, 카로틴 등에 의해 결정되는데, 이 중에서 멜라닌이 가장 중요한 역할을 한다. 멜라닌(Melanin)은 피부의 표피층에 존재하는 색소로서, 자외선으로 인한 피부 손상을 막아주며, 피부 생체 내에 생겨난 유해산소 및 프리라디칼 등을 잡아주는 등 외부 유해인자로부터 피부를 보호해주는 유용한 역할을 수행한다.Human skin color is largely determined by the amount of melanin, hemoglobin, carotene and the like, of which melanin plays the most important role. Melanin is a pigment in the skin's epidermal layer that prevents skin damage caused by UV rays and protects the skin from external harmful factors such as trapping free radicals and free radicals generated in skin. .

멜라닌의 합성 과정을 살펴보면, 멜라노사이트(Melanocyte) 내의 멜라노좀(Melanosome)이라는 소포체에 존재하는 티로시나아제(Tyrosinase)라는 효소가 티로신(Tyrosine)을 기질로 하여 도파퀴논(DOPAquinone)을 생성하고, 도파퀴논이 자동 산화반응을 거쳐 도파크롬(DOPAchrome)이 된다. 다시 도파크롬은 효소 반응에 의해 멜라닌이 생성된다. 이렇게 생성된 멜라닌은 멜라노좀을 통해 각질세포로 옮겨지고 여기에서 약 28일간의 각화 과정을 거치면서 피부 표면으로 나와 각질과 함께 소실된다.In the process of synthesizing melanin, an enzyme called Tyrosinase, which is present in the melanocyte vesicles of Melanosome, produces dopaquinone using Tyrosine as a substrate. Quinones undergo an automatic oxidation reaction to become dopachrome. Dopachrome again produces melanin by enzymatic reaction. The melanin thus produced is transferred to the keratinocytes through the melanosomes, and after about 28 days of keratinization, the melanin comes out to the surface of the skin and disappears with the keratin.

피부 조직에서는 자외선으로부터 몸을 보호하기 위해 멜라닌을 합성하지만 멜라닌은 외부의 여러 요인에 의해 합성이 촉진되며, 스트레스, 피부 노화 등에 의해 각질층의 탈락이 원활하게 이루어지지 않게 된다. 결국 노후화된 각질이 정상적으로 탈락되지 않게 되면 피부가 활성을 잃고, 피부표면에 남아 기미, 주근께 등의 색소 침착이 일어나 피부톤이 어두워지게 된다. Skin tissue synthesizes melanin to protect the body from ultraviolet rays, but melanin is promoted by various factors, and the stratum corneum is not smoothed out due to stress and skin aging. Eventually, when the aging keratin is not eliminated normally, the skin loses activity and remains on the skin, causing pigmentation such as blemishes and freckles, resulting in dark skin tone.

따라서, 이러한 색소 침착현상을 막아주기 위해서는 멜라닌 색소의 합성을 저해하거나 묵은 각질층을 제거해 줄 필요가 있다. 멜라닌 합성을 저해하는 기작은 여러 가지 존재한다. 대표적인 합성 저해 과정은 멜라닌 합성의 중요한 효소인 티로시나제를 저해하는 것으로, 가장 많이 알려진 것으로는 코직산(kojic acid), 비타민 C(Vitamin C), 알부틴(Arbutin)등의 물질이 있다. 그리고 노화된 각질을 제거하기 위해 AHA (α-hydroxy acid)를 활용하여 피부의 각질층을 제거하거나, 스크럽제 및 연마제 등을 활용해서 마찰을 통해 각질세포를 물리적으로 제거하는 경우가 있다.Therefore, in order to prevent such pigmentation phenomenon, it is necessary to inhibit the synthesis of melanin pigment or to remove the old stratum corneum. There are several mechanisms that inhibit melanin synthesis. Representative synthesis inhibition process inhibits tyrosinase, an important enzyme of melanin synthesis, and most commonly known substances include kojic acid, vitamin C, and arbutin. In order to remove aged keratin, AHA (α-hydroxy acid) is used to remove the stratum corneum of the skin or scrub and abrasives to remove keratinocytes physically through friction.

그러나, 피부 미백 효과를 얻기 위해 한 과정만 저해하여 효과를 얻고자 하는 방법이 일반적으로 연구되고 있기 때문에 아직 뛰어난 미백 효과를 나타내지도 못하고 있는 실정이다. 따라서 충분한 미백효과를 얻기 위하여 멜라닌의 생합성을 억제하며 동시에 묵은 각질의 탈락을 촉진하는 방법이 필요한다.However, in order to obtain an effect by inhibiting only one process to obtain a skin whitening effect, the researches have not yet exhibited an excellent whitening effect. Therefore, in order to obtain a sufficient whitening effect, a method of inhibiting melanin biosynthesis and promoting the exfoliation of old keratin is required.

이에, 본 발명자들은 피부 미백 효과를 증진하기 위하여 연구한 결과, 미백 효과가 우수한 비타민C와 키위에서 유래된 악티니딘을 사용할 경우, 묵은 각질층을 제거하여 미백 효과가 극대화 될 수 있는 것을 발견하고 본 발명을 완성하였다.Thus, the present inventors have studied in order to enhance the skin whitening effect, when using the vitamin C and kiwi derived actinidine excellent in whitening effect, found that the whitening effect can be maximized by removing the old stratum corneum The invention was completed.

따라서, 본 발명의 목적은 비타민 C와 키위 유래의 악티니딘을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공하는데 있다. Accordingly, it is an object of the present invention to provide a cosmetic composition for skin whitening containing vitamin C and actinidine derived from kiwi as an active ingredient.

상술한 과제를 해결하기 위하여 본 발명은 다음과 같은 수단을 포함할 수 있다.In order to solve the above problems, the present invention may include the following means.

본 발명의 일실시예에 따른 피부 미백용 화장료 조성물은, 비타민C와 키위에서 유래된 악티니딘을 유효성분으로 함유하는 것을 특징으로 한다.The cosmetic composition for skin whitening according to the embodiment of the present invention is characterized by containing actinidine derived from vitamin C and kiwi as an active ingredient.

상기 비타민C는 조성물 총 중량에 대해서 0.01 ~ 10.0중량%를 함유하는 것을 특징으로 한다.The vitamin C is characterized by containing 0.01 to 10.0% by weight based on the total weight of the composition.

상기 악티니딘은 조성물 총 중량에 대해서 0.001 ~ 10.0중량%을 함유하는 것을 특징으로 한다.The actinidine is characterized in that it contains 0.001 to 10.0% by weight based on the total weight of the composition.

상기 조성물은 유연화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 한다.The composition is characterized in that it has a formulation selected from the group consisting of softener, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.

본 발명은 미백효과가 우수한 비타민C와 키위에서 유래된 악티니딘이 각질층의 제거를 촉진하여 피부의 자극없이 피부 미백효과의 상승작용이 뛰어난 효과를 제공한다.The present invention provides a synergistic effect of the skin whitening effect without skin irritation by promoting the removal of the stratum corneum derived from vitamin C and kiwi having excellent whitening effect.

본 발명에 따른 피부미백용화장료 조성물은 비타민 C와 키위 유래의 악티니딘을 유효성분으로 함유하여 피부 미백 효과가 더욱 상승하도록 한다. The cosmetic composition for skin whitening according to the present invention contains the actinin from vitamin C and kiwi as an active ingredient to further increase the skin whitening effect.

본 발명의 유효성분인 비타민 C는 화장품 원료로서 종래부터 사용되던 것으로 기미, 주근깨, 검버섯 등 색소 침착의 개선 등의 미백효과와 항산화 및 콜라겐 생합성 촉진 등의 주름개선 효과 그리고 보습효과 등의 기능이 잘 알려져 있다. Vitamin C, an active ingredient of the present invention, has been conventionally used as a cosmetic ingredient, and has a whitening effect such as improvement of pigmentation such as blemishes, freckles, and blotch, and wrinkle improvement effect such as antioxidant and collagen biosynthesis promotion, and moisturizing effect. Known.

본 발명의 유효성분인 악티니딘은 키위에서 추출한 단백질분해효소로서, 이미 잘 알려진 식물성 단백질분해효소인 파파인(Papain), 브로멜라인(Bromelain), 피신(Ficin), 키모파파인(Chymopapain)과 같은 군에 속한다. 이들은 -SH기를 가지는 thiol계의 단백질분해효소로서 맥주의 혼탁방지제, 연육용, 소화제, 제빵 등 식품공업 등에서 널리 이용되고 있다. Actinidine, an active ingredient of the present invention, is a proteolytic enzyme extracted from kiwi, and is well known as plant proteinases such as papain, bromelain, ficin, and chemopapain. Belongs to the military. These are thiol-based proteolytic enzymes having -SH groups and are widely used in the food industry such as beer turbidity inhibitors, for meat removal, digestive agents and baking.

본 발명에 이용되는 키위(Actinidia chinensis)는 중국 양자강 부근에서 서식하던 아열대성 식물로, 뉴질랜드에서 개량되어 전세계적으로 재배되고 있다. 키위는 다래나무과의 낙엽덩굴식물로 잎은 어긋나고 둥근 모양이거나 둥근 달걀 모양 또는 달걀을 거꾸로 세운 모양이며 끝이 팼고 가장자리에 가시 같은 톱니가 있으며 뒷면에 가 빽빽이 있다. 꽃은 6∼7월에 흰색으로 피며, 열매는 8∼10월에 익고 둥근 달걀 모양 또는 원기둥 모양이며 표면에 갈색 털이 빽빽이 있다. 열매가 뉴질랜드에 서식하는 키위 새처럼 생겼다고 하여 영어 이름이 키위이다. 한국에서는 1977년에 뉴질랜드에서 도입해 남해안에서에서 주로 재배되고 있다. 한편, 본 발명에서 이용되는 키위로부터 단백질 분해효소인 악티니딘을 분리정제하기 위하여 Cho. et al,;Korean J. Food & Nutrition., Vol 7, No2, pp87-94, 1994의 방법에 따라 추출하였다. Actinidia chinensis used in the present invention is a subtropical plant inhabiting the Yangtze River in China, which is improved in New Zealand and cultivated worldwide. Kiwi is a deciduous plant of the genus Aceraceae. The leaves are alternate and round, round or round, or upside down. Flowers blossom in white in June-July. Fruits ripen in August-October, round egg-shaped or cylindrical, with dense brown hairs on the surface. The fruit is shaped like a kiwi bird living in New Zealand. In Korea, it was introduced in New Zealand in 1977 and is grown mainly in the south coast. On the other hand, in order to isolate and purify actinide, a protease from the kiwi used in the present invention, Cho. et al ,; Korean J. Food & Nutrition., Vol 7, No2, pp87-94, 1994.

본 발명의 키위로부터 악티니딘을 분리하는 방법은The method for separating actinidine from the kiwi of the present invention

1) 키위로부터 상등액을 회수하는 단계1) recovering the supernatant from the kiwi

2) 아세톤 분획을 하는 단계2) acetone fractionation

3) 상기 분획물을 크로마토그래피에 적용하여 활성분획을 용출하는 단계3) eluting the active fraction by applying the fraction to chromatography

4) 상기 용출액을 폴리아크릴아마이드 전기영동을 통해 정제여부를 확인4) Check whether the eluate is purified through polyacrylamide electrophoresis

상기 단계 3의 크로마토그래피는 이온교환 크로마토그래피를 수행한 후에 겔여과 크로마토그래피를 사용하였다. 본 발명의 제조예에서는 이온교환 크로마토그래피칼럼에 상기 단계2의 분획을 부가한 후 활성 분획을 용출하였다. 다음으로 겔여과 칼럼에 상기 이온교환 크로마토그래피에서 얻은 분획을 칼럼에 부가하여 활성분획을 용출하고 활성도를 측정하였다. 상기와 같이 분리된 단백질분해효소가 순수분리 되었는지 확인하기 위해, 상기 용출액을 사용하여 폴리아크릴아미드 겔 전기영동을 수행하여 단백질분해효소를 분리 정제하였다. The chromatography of step 3 was subjected to ion exchange chromatography followed by gel filtration chromatography. In the preparation of the present invention, the active fraction was eluted after adding the fraction of step 2 to the ion exchange chromatography column. Next, the fraction obtained by the ion exchange chromatography was added to the gel filtration column to the column to elute the active fraction and the activity was measured. In order to confirm that the separated protease was purely separated as described above, the protease was separated and purified by performing polyacrylamide gel electrophoresis using the eluate.

한편, 상기 비타민C는 화장료 조성물 총 중량에 대하여 0.01 ~ 10.0 중량%를 함유하는 것을 특징으로 한다. 상기 비타민C의 함량이 0.01 중량% 미만인 경우는 미백효과의 효과가 미미하며, 10.0 중량%를 초과하는 경우는 피부 자극의 위험이 있다.On the other hand, the vitamin C is characterized in that it contains 0.01 to 10.0% by weight based on the total weight of the cosmetic composition. When the content of the vitamin C is less than 0.01% by weight, the effect of the whitening effect is insignificant, and when the content of more than 10.0% by weight there is a risk of skin irritation.

상기 악티니딘의 함량은 0.001 ~ 10.0중량%를 함유하는 것을 특징으로 하며, 상기 악티니딘의 함량이 0.001중량%미만일 경우 각질 박리 촉진 효과가 미미하며 10.0 중량%를 초과할 경우에는 그 효과를 기대하기 어렵다. The content of the actinidine is characterized in that it contains 0.001 ~ 10.0% by weight, when the content of the actinidine is less than 0.001% by weight keratin exfoliation promoting effect is insignificant, when the content exceeds 10.0% by weight It's hard to expect.

본 발명의 화장료 조성물에 포함되는 유효성분은 비타민C와 악티니딘 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하여, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 함유제 등을 포함한다.  The active ingredient included in the cosmetic composition of the present invention includes components conventionally used in cosmetic compositions in addition to vitamin C and actinidine, such as conventional containing such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavorings. And the like.

이하, 실시 예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시 예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시 예에 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to the following examples. These examples are only for illustrating the present invention in more detail, and the scope of the present invention is not limited to these embodiments according to the gist of the present invention to those skilled in the art to which the present invention pertains. Will be self explanatory.

[제조예 1]키위로부터 악티니딘의 분리 정제Preparation Example 1 Separation and Purification of Actinidine from Kiwi

시중에서 1kg의 제주도산 키위를 구입하여 분쇄기를 이용하여 분쇄한 후 인산염 완충용액(5mM cystein과 2mM EDTA를 함유한 20mM 인산염 완충용액, pH 7.0)을 분쇄물의 2배에 해당하는 양을 첨가한 후 균질기로 5분간 균질화시켰다. 이것을 원심분리(12,000rpm, 30분)하여 상등액을 조효소로 사용하였다. After purchasing 1kg of Jeju Dosan Kiwi in the market, it was pulverized using a pulverizer and phosphate buffer solution (20mM phosphate buffer solution containing 5mM cystein and 2mM EDTA, pH 7.0) was added to twice the amount of the pulverized product. The homogenizer was homogenized for 5 minutes. This was centrifuged (12,000 rpm, 30 minutes) and the supernatant was used as a coenzyme.

조효소액 300ml에 동량의 아세톤을 가하여 실온에서 2시간 동안 방치 후 침전물을 얻었다. 이것을 다시 원심분리(4000rpm, 10분)하여 상등액을 제거한 다음 감압건조하여 아세톤파우더를 얻었다.The same amount of acetone was added to 300 ml of the crude enzyme solution and left at room temperature for 2 hours to obtain a precipitate. This was again centrifuged (4000 rpm, 10 minutes) to remove the supernatant and dried under reduced pressure to obtain acetone powder.

아세톤파우더를 인산염 완충용액(pH 7.0)에 녹여 DEAE-Toyopearl 650C column(2.5×28cm, Torsoh, Japan)에 주입한 후 인산염 완충용액(pH 7.0)으로 세척한 다음, 200mM NaCl를 이용하여 1ml/min 속도로 용출한 다음, 한외여과(Amicon Co. PM-10)을 이용하여 농축한 후, Sephadex G-100 column(1.8×60cm, Pharmacia LKB Biotechnology, Sweden)에 농축된 효소액을 주입하여 인산염 완충용액(pH 7.0)으로 9ml/h의 속도로 용출 분획하고 활성도를 측정하여 사용하였다.Acetone powder was dissolved in phosphate buffer (pH 7.0) and injected into DEAE-Toyopearl 650C column (2.5 × 28cm, Torsoh, Japan), washed with phosphate buffer (pH 7.0), and then 1ml / min with 200mM NaCl. After eluting at a rate and concentrated using ultrafiltration (Amicon Co. PM-10), the concentrated enzyme solution was injected into a Sephadex G-100 column (1.8 × 60 cm, Pharmacia LKB Biotechnology, Sweden) and phosphate buffer solution ( pH 7.0) was eluted at a rate of 9 ml / h and the activity was measured and used.

단백질 분해효소의 활성을 분석하기 위하여, 용출액을 회수하여 활성을 측정하였다. 구체적으로, 완충용액(pH 7.0)에 최종 농도가 1.2%가 되게 카제인(casein)을 녹인 기질 용액 3.0 ㎖에 효소 용액 0.1 ㎖을 가하여 잘 섞어준 후 35℃ 에서 10 분간 반응시키고 10% 트리클로르 아세트산(TCA) 0.5 ㎖를 가하여 10 분간 방치하여 반응을 중단시켰다. 반응액을 원심 분리(2800rpm, 10분)하여 275 nm에서 생성된 티로신 양을 측정하였다. 이 때, 단백질분해효소 1 유니트(Unit)는 1분 동안에 1 마이크로그람(㎍)의 티로신 생성에 필요한 효소의 양으로 정의하였다.In order to analyze the activity of the protease, the eluate was recovered and measured for activity. Specifically, 0.1 ml of enzyme solution was added to 3.0 ml of a substrate solution in which casein was dissolved in a buffer solution (pH 7.0) so that the final concentration was 1.2%, and the mixture was mixed well and reacted at 35 ° C. for 10 minutes, followed by 10% trichlor acetic acid. 0.5 ml (TCA) was added and left to stand for 10 minutes to stop the reaction. The reaction solution was centrifuged (2800 rpm, 10 minutes) to measure the amount of tyrosine produced at 275 nm. At this time, one unit of protease was defined as the amount of enzyme required to generate 1 microgram (μg) of tyrosine in 1 minute.

단백질분해효소의 정제여부를 확인하기 위해 7.5% 폴리아크릴아마이드젤을 이용하여 0.15M Tris-glycine완충용액(pH 6.8)에서 전기영동을 한 다음, 젤은 0.025% coomassie brilliant blue R-250용액으로 염색하여 단일 밴드임을 확인하였다. Electrophoresis was performed on 0.15M Tris-glycine buffer solution (pH 6.8) using 7.5% polyacrylamide gel to confirm the proteolytic enzyme purification.The gel was then stained with 0.025% coomassie brilliant blue R-250 solution. It was confirmed that it is a single band.

단계step 단백질분해효소 활성(unit)Protease activity (unit) DEAE-Toyopearl 650C DEAE-Toyopearl 650C 24502450 Sephadex G-100 Sephadex G-100 19871987

[제조예 2][Production Example 2]

하기표 1 조성비를 가지는 크림 형태로 비타민 C와 키위에서 얻은 악티니딘을 함유하는 화장료 조성물을 제조하였다.To prepare a cosmetic composition containing the actinidine obtained from vitamin C and kiwi in the form of a cream having a composition ratio.

성분ingredient 실시예 1
(중량%)
Example 1
(weight%)
실시예 2
(중량%
Example 2
(weight%
실시예 3
(중량%)
Example 3
(weight%)
비교예
(중량%)
Comparative example
(weight%)
비타민 C Vitamin c 3.03.0 3.03.0 악티니딘Actinidine 1.01.0 1.01.0 글리세린glycerin 5.05.0 5.05.0 5.05.0 5.05.0 유동파라핀Liquid paraffin 10.010.0 10.010.0 10.010.0 10.010.0 폴리솔베이트60Polysorbate 60 2.02.0 2.02.0 2.02.0 2.02.0 솔비탄세스퀴롤올레이트Sorbitan sesquirololeate 1.01.0 1.01.0 1.01.0 1.01.0 스쿠알란Squalane 5.05.0 5.05.0 5.05.0 5.05.0 밀납Beeswax 10.010.0 10.010.0 10.010.0 10.010.0 트리에탄올아민Triethanolamine 0.50.5 0.50.5 0.50.5 0.50.5 프로필렌 글리콜Propylene glycol 1.01.0 1.01.0 1.01.0 1.01.0 카르복실비닐폴리머Carboxyl Vinyl Polymer 1.51.5 1.51.5 1.51.5 1.51.5 incense 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 방부제antiseptic 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 정제수Purified water 잔량Balance 잔량Balance 잔량Balance 잔량Balance system 100100 100100 100100 100100

[실험예 2] 피부첩포시험Experimental Example 2 Skin Patch Test

과거력상 피부자극에 과민반응을 보인 적이 없으며, 현재 피부병 내지 피부 알러지 증상이 없는 20-30대 여성 20명을 대상으로 본 발명의 피부안전성을 확인하기 위하여 인체 피부 첩포시험을 하였다. 우선 시험부위를 70% 에탄올로 닦아낸 뒤 건조시켰다. 준비된 시험물질을 15㎍씩 핀챔버 (Finn chamber, 100x10, EPITEST, 핀란드) 내에 적하시킨 후 시험대상자의 전박 (forearm) 안쪽 부위에 밀폐 첩포하였다. 24시간 동안 첩포하고 첩포를 제거한 후 펜으로 시험부위를 표시하였다. 표시 후 각각 1시간 및 24시간 후에 확대경 (8MC-150, DAZOR, 미합중국)을 이용하여 시험 부위를 관찰하여 홍반 및 부종 유무를 관찰하였다. 피부반응은 국제접촉피부염연구회 (ICDRG, International Contact Dermaitis Research Group)의 규정에 따라 판정하고, 수학식 1에 따라 평균피부반응도(mean response rate)를 구하였다. 그 결과는 표 2에 제시된다.In the past, skin irritation has not been shown to be irritable, and a skin test was performed on 20 women in their 20s and 30s with no skin disease or skin allergy symptoms to confirm the skin safety of the present invention. First the test site was wiped with 70% ethanol and dried. 15 μg of the prepared test substance was dropped in a Fin chamber (Finn chamber, 100 × 10, EPITEST, Finland), and then sealed in the forearm inner part of the test subject. The patch was marked for 24 hours, the patch was removed, and the test site was marked with a pen. 1 hour and 24 hours after marking, the test site was observed using a magnifying glass (8MC-150, DAZOR, United States of America) to observe erythema and edema. Skin response was determined according to the regulations of the International Contact Dermaitis Research Group (ICDRG), and the average skin response rate was calculated according to Equation 1. The results are shown in Table 2.

[피부반응의 평가 기준 및 점수][Evaluation Criteria and Score of Skin Response]

Figure 112010007005311-pat00001
Figure 112010007005311-pat00001

Figure 112010007005311-pat00002
Figure 112010007005311-pat00002

시험물질Test substance 1 시간 후After 1 hour 24 시간 후After 24 hours 반응도 (%)
(n=20)
Reactivity (%)
(n = 20)
±  ± ++ ++++ ±± ++ ++++ 실시예 1Example 1 - - -- -- -- -- -- 0.000.00 실시예 2Example 2 - - - - - - - - - - - - 0.000.00 실시예 3Example 3 - - - - - - - - - - - - 0.000.00 비교예 Comparative example - - - - - - - - - - - - 0.000.00

상기 표 3에서 알 수 있듯이, 피부첩포실험에서 비타민 C와 악티니딘을 함유한 화장료에서 피부자극이 나타나지 않아 피부 안전성이 우수함을 알 수 있다.As can be seen in Table 3, it can be seen that the skin safety test is excellent because the skin irritation does not appear in the cosmetics containing vitamin C and actinidine in the skin patch test.

[실험예 1]피부 미백 효과Experimental Example 1 Skin Whitening Effect

상기 제조예 1에서 제조한 실시예 1,2,3 및 비교예의 피부 미백 효과를 알아보기 위해 30-40대의 피부톤이 검은 여성을 대상으로 10명씩 4개군으로 나누어 실험하였다. 안면 전체에 고르게 하루 2회씩 4주간 도포한 후 피부색의 밝기 정도를 크로마미터(Minolta CM-3500d)를 이용하여 측정하였다. 시험물질이 미백효과가 있는 경우는 △ L값(도포 후 피부밝기 -도포전의 피부밝기)이 증가되어 나타나며, 그 결과는 하기 표3에 나타나 있다.In order to examine the skin whitening effects of Examples 1, 2, and 3 and Comparative Example prepared in Preparation Example 1, the experiment was divided into four groups of 10 people with black skin tones in their 30-40s. After applying evenly to the entire face twice a day for 4 weeks, the brightness of the skin color was measured using a chromameter (Minolta CM-3500d). When the test substance has a whitening effect, △ L value (skin brightness after application-skin brightness before application) is increased, and the results are shown in Table 3 below.

피부색 변화 (△L)Skin color change (△ L) 1주1 week 2주2 weeks 3주3 weeks 4주4 Weeks 실시예 1Example 1 1.21.2 2.52.5 3.63.6 5.35.3 실시예 2Example 2 0.60.6 1.21.2 1.91.9 2.22.2 실시예 3Example 3 0.40.4 0.80.8 1.41.4 1.71.7 비교예 1Comparative Example 1 0.20.2 0.30.3 0.40.4 0.40.4

상기 표 4에서 알 수 있듯이 유효성분이 함유된 실시예 1,2,3에서 피부색의 밝기 변화가 나타남을 보였다. 특히 비타민C와 악티니딘이 함유된 실시예 1의 경우 유효성분을 단독으로 사용하는 것보다 피부 미백효과가 매우 상승됨을 확인할 수 있었다.As can be seen in Table 4, Examples 1, 2 and 3 containing the active ingredient showed that the change in the brightness of the skin color appeared. In particular, in the case of Example 1 containing vitamin C and actinidine it was confirmed that the skin whitening effect is significantly higher than using the active ingredient alone.

이하, 본 발명의 화장료 제형예로서 본 발명의 유효성분인 비타민C와 악티니딘을 함유하는 크림, 로션, 에센스, 팩 및 보디 클린저를 예시하고 있으나, 본 발명의 화장료의 제형이 반드시 이에 한정되는 것은 아니다.Hereinafter, as an example of the cosmetic formulation of the present invention, creams, lotions, essences, packs, and body cleansers containing vitamin C and actinidine, which are the active ingredients of the present invention, are exemplified, but the formulation of the present invention is not limited thereto. It is not.

[제형예 1]크림 Formulation Example 1 Cream

상기의 유효성분을 함유하는 크림을 통상의 방법에 따라 제조하였다.
The cream containing the said active ingredient was manufactured according to a conventional method.

원료명Raw material name 함량 (중량%)Content (% by weight) 비타민CVitamin C 3.03.0 악티니딘Actinidine 1.01.0 글리세린glycerin 4.04.0 바세린Vaseline 3.53.5 트리에탄올아민Triethanolamine 0.50.5 유동파라핀Liquid paraffin 24.024.0 스쿠알란Squalane 3.03.0 밀납Beeswax 2.12.1 토코페릴아세테이트Tocopheryl acetate 0.10.1 폴리솔베이트 60Polysorbate 60 2.42.4 카르복실비닐폴리머Carboxyl Vinyl Polymer 1.01.0 솔비탄세스퀴올레이트Sorbitan sesquioleate 2.32.3 incense 미량a very small amount 방부제antiseptic 미량a very small amount 정제수Purified water 잔량Balance system 100100

[제형예 2]로션[Formulation Example 2] Lotion

상기의 유효성분을 함유하는 로션을 통상의 방법에 따라 제조하였다.The lotion containing the said active ingredient was manufactured according to a conventional method.

원료명Raw material name 함량 (중량%)Content (% by weight) 비타민CVitamin C 3.03.0 악티니딘Actinidine 1.01.0 세토스테아릴 알코올Cetostearyl alcohol 1.01.0 글리세릴모노스테아레이트Glyceryl Monostearate 0.80.8 소르비탄모노스테아레이트Sorbitan monostearate 0.30.3 폴리솔베이트 60Polysorbate 60 1.01.0 미네랄오일Mineral oil 5.05.0 사이크로메치콘Pyromethicone 3.03.0 디메치콘Dimethicone 0.50.5 알란토인Allantoin 0.10.1 글리세린glycerin 5.05.0 알코올Alcohol 22 프로필렌글리콜Propylene glycol 3.03.0 incense 미량a very small amount 방부제antiseptic 미량a very small amount 정제수Purified water 잔량Balance system 100100

[제형예 3]에센스Formulation Example 3 Essence

상기의 유효성분을 함유하는 에센스를 통상의 방법에 따라 제조하였다.
Essences containing the active ingredient was prepared according to a conventional method.

원료명Raw material name 함량 (중량%)Content (% by weight) 비타민CVitamin C 3.03.0 악티니딘Actinidine 1.01.0 1,3-부틸렌글리콜1,3-butylene glycol 4.04.0 글리세린glycerin 3.03.0 알란토인Allantoin 0.50.5 판테놀Panthenol 0.10.1 EDTA-2NaEDTA-2Na 0.010.01 에탄올ethanol 5.05.0 트리에탄올아민Triethanolamine 1.51.5 스쿠알란Squalane 2.02.0 밀납Beeswax 2.52.5 폴리솔베이트60Polysorbate 60 3.53.5 카르복실비닐폴리머Carboxyl Vinyl Polymer 1.01.0 솔비탄세스퀴올레이트Sorbitan sesquioleate 2.52.5 incense 미량a very small amount 방부제antiseptic 미량a very small amount 정제수Purified water 잔량Balance system 100100

[제형예 4]팩[Formulation Example 4] Pack

상기의 유효성분을 함유하는 팩을 통상의 방법에 따라 제조하였다.The pack containing the said active ingredient was manufactured according to a conventional method.

원료명Raw material name 함량 (중량%)Content (% by weight) 비타민CVitamin C 3.03.0 악티니딘Actinidine 1.01.0 에틸알코올Ethyl alcohol 3.03.0 EDTA-2NaEDTA-2Na 0.050.05 프로필렌 글리콜Propylene glycol 5.05.0 글리세린glycerin 4.54.5 카보폴Cabopol 1.51.5 폴리옥사이드Polyoxide 0.20.2 방부제antiseptic 미량a very small amount incense 미량a very small amount 정제수Purified water 잔량Balance system 100100

[제형예 5]바디 클렌저Formulation Example 5 Body Cleanser

상기의 유효성분을 함유하는 바디 클렌저를 통상의 방법에 따라 제조하였다.
A body cleanser containing the above active ingredient was prepared according to a conventional method.

원료명Raw material name 함량 (중량%)Content (% by weight) 비타민CVitamin C 3.03.0 악티니딘Actinidine 1.01.0 알킬에텔당산염 (30%)Alkyl ether saccharide (30%) 30.030.0 알킬에텔설포석신산염 (30%)Alkyl ether sulfosuccinate (30%) 20.020.0 알킬아미도베타인 (30%)Alkylamidobetaine (30%) 5.05.0 프로필렌글리콜Propylene glycol 5.05.0 베타인Betaine 5.05.0 라우라미드디이에이Lauramiddiei 4.04.0 셀룰로스검Cellulose gum 0.050.05 가수분해단백질Hydrolyzed protein 0.10.1 구연산Citric acid 미량a very small amount NaClNaCl 미량a very small amount incense 미량a very small amount 방부제antiseptic 미량a very small amount 정제수Purified water 잔량Balance system 100100

Claims (4)

비타민C와 키위에서 유래된 악티니딘을 유효성분으로 함유하는 것을 특징으로 피부 미백용 화장료 조성물.A cosmetic composition for skin whitening, comprising actinidine derived from vitamin C and kiwi as an active ingredient. 제 1항에 있어서, 비타민C는 조성물 총 중량에 대해서 0.01 ~ 10.0중량%를 함유하는 것을 특징으로 하는 피부 미백용 화장료 조성물.The cosmetic composition for skin whitening according to claim 1, wherein the vitamin C contains 0.01 to 10.0 wt% based on the total weight of the composition. 제 1항에 있어서, 악티니딘은 조성물 총 중량에 대해서 0.001 ~ 10.0중량%을 함유하는 것을 특징으로 하는 피부 미백용 화장료 조성물.The cosmetic composition for skin whitening according to claim 1, wherein the actinidine contains 0.001 to 10.0% by weight based on the total weight of the composition. 제 1항 내지 제 3 항 중 어느 하나의 항에 있어서, 상기 조성물은 유연화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 하는 피부 미백용 화장료 조성물.The composition according to any one of claims 1 to 3, wherein the composition is a softener, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder. Cosmetic composition for skin whitening, characterized in that it has a formulation selected from the group consisting of.
KR1020100009333A 2010-02-01 2010-02-01 Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi KR101064934B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100009333A KR101064934B1 (en) 2010-02-01 2010-02-01 Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100009333A KR101064934B1 (en) 2010-02-01 2010-02-01 Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi

Publications (2)

Publication Number Publication Date
KR20110089786A KR20110089786A (en) 2011-08-09
KR101064934B1 true KR101064934B1 (en) 2011-09-16

Family

ID=44927729

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100009333A KR101064934B1 (en) 2010-02-01 2010-02-01 Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi

Country Status (1)

Country Link
KR (1) KR101064934B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101315975B1 (en) * 2011-11-22 2013-10-08 재단법인나주시천연염색문화재단 Composition for removing callus comprising kiwi extract

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001151696A (en) 1999-11-22 2001-06-05 Keiko Tanaka Agent which is obtained from actinidine and is used for removing protein cell different from enzyme for inhibiting proliferation and metastasis of tumor
JP2001206836A (en) 2000-01-27 2001-07-31 Kose Corp Skin preparation for external use
JP2003040769A (en) 2001-07-26 2003-02-13 Noevir Co Ltd Skin care preparation
US20070110682A1 (en) 2005-11-17 2007-05-17 Chantal Bergeron Non-peroxide preparation for whitening natural and manufactured teeth

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001151696A (en) 1999-11-22 2001-06-05 Keiko Tanaka Agent which is obtained from actinidine and is used for removing protein cell different from enzyme for inhibiting proliferation and metastasis of tumor
JP2001206836A (en) 2000-01-27 2001-07-31 Kose Corp Skin preparation for external use
JP2003040769A (en) 2001-07-26 2003-02-13 Noevir Co Ltd Skin care preparation
US20070110682A1 (en) 2005-11-17 2007-05-17 Chantal Bergeron Non-peroxide preparation for whitening natural and manufactured teeth

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101315975B1 (en) * 2011-11-22 2013-10-08 재단법인나주시천연염색문화재단 Composition for removing callus comprising kiwi extract

Also Published As

Publication number Publication date
KR20110089786A (en) 2011-08-09

Similar Documents

Publication Publication Date Title
CN111201012A (en) Cosmetic composition for skin whitening and wrinkle improvement comprising centella asiatica adventitious root extract as active ingredient
KR102304419B1 (en) Multifunctional cosmetic composition that contains amino acids and peptides derived from Moringa seeds, effective for skin moisturizing, skin whitening, maintaining and improving skin elasticity, and preventing skin wrinkles
KR101885195B1 (en) Cosmetic Composition with Fermentative Extract of Osmanthus fragrans
KR20160123732A (en) Cosmetic composition comprising the extract of cynara scolymus and brassica oleracea var. botrytis as active ingredient
KR100710657B1 (en) Whitening cosmetic composition containing dihydroquercetin
KR20170076147A (en) Composition for improving skin
KR101781545B1 (en) A cosmetic composition for skin whitening comprising the extract of saccharina japonica as active ingredient
KR101095609B1 (en) Cosmetic composition containing whitening Composition for whitening Skin
KR100882744B1 (en) Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew
KR20180065166A (en) Cosmetic composition for skin whitening containing pancratium maritimum extract and blue lotus extract
KR102016909B1 (en) Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder
KR101064934B1 (en) Cosmetic composition for skin whitening containing actinin derived from vitamin C and kiwi
KR101009767B1 (en) Cosmetic Composition for Desquamation Containing a Papain and the Extract of Nopal
KR100530669B1 (en) Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening
KR102632084B1 (en) Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract
KR100744947B1 (en) Cosmetic Composition for Skin Whitening Comprising Extract of Cnidium officinale and Protease as Active Ingredients
KR101948661B1 (en) Cosmetic composition for skin whitening containing magnolia sieboldii extract ripened at low-temperature using bamboo charcoal
KR101677460B1 (en) Cosmetic composition comprising allergen removed water soluble royal jelly for skin whitening and anti-aging activity
KR101317433B1 (en) The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage
KR101996547B1 (en) Cosmetic composition with skin whitening effect containing diphylleia grayi extract
KR100538078B1 (en) Cosmetic Compositions Comprising Panax ginseng (C.A. MEY) Extract and Plant Extracts as Oriental Medicine for Preventing Skin Aging
KR100713557B1 (en) Cosmetic composition for skin whitening comprising ramulus mori extract and hexanoyl-tripeptide as active ingredient
KR20080098925A (en) Cometic compositions containing extract of paeonia suffruticosa andrew
KR101176525B1 (en) Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient
KR100678865B1 (en) Cosmetic composition for skin whitening comprising ramulus mori extract and carnitine as active ingredient

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140711

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20150826

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20160601

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20170605

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20180605

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20190813

Year of fee payment: 9